Abstract
Immediate-release oral dosage forms, also known as IR dosage forms, are widely favoured for medication delivery due to their rapid dissolution rate. This characteristic enables the medication to quickly enter the bloodstream, offering swift relief to patients. In formulation development, dissolution is a critical factor, providing essential insights for quality control. In vitro dissolution tests-a laboratory method simulating the medication's dissolution in the body—plays a key role across various stages of drug development. From a regulatory standpoint, validating dissolution enhances the review process for preclinical and clinical data. In certain situations, dissolution test results may also be utilized to assess the biopharmaceutical impact of product modifications. Such testing ensures that medications are not only effective but also safe and dependable for patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call